Sysmex (OTCMKTS:SSMXY) Sees Unusually-High Trading Volume – Here’s What Happened

Sysmex Corporation ADR (OTCMKTS:SSMXY) saw unusually-high trading volume on Tuesday . Approximately 557,534 shares changed hands during trading, an increase of 256% from the previous session’s volume of 156,483 shares.The stock last traded at $9.89 and had previously closed at $9.72.

Analyst Upgrades and Downgrades

Separately, The Goldman Sachs Group upgraded Sysmex from a “hold” rating to a “buy” rating in a research report on Thursday, October 9th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.

Sysmex Price Performance

The firm has a market capitalization of $6.23 billion, a P/E ratio of 19.81 and a beta of 1.17. The company has a current ratio of 3.34, a quick ratio of 2.49 and a debt-to-equity ratio of 0.11. The firm has a 50 day moving average price of $10.63 and a 200-day moving average price of $13.45.

Sysmex (OTCMKTS:SSMXY) last released its earnings results on Wednesday, November 5th. The company reported $0.16 earnings per share for the quarter, meeting the consensus estimate of $0.16. Sysmex had a return on equity of 9.86% and a net margin of 9.32%.The firm had revenue of $826.60 million for the quarter, compared to the consensus estimate of $880.80 million. On average, analysts expect that Sysmex Corporation ADR will post 0.57 earnings per share for the current year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.